Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jul 2021. Module: SNOMED CT United Kingdom clinical extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2848741000000112 | Proprotein convertase subtilisin/kexin type 9 inhibitor indicated (situation) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| 2848751000000110 | PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor indicated | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom clinical extension module |
| 2848761000000113 | Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | en | Synonym | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Temporal context | Current or specified time | true | Inferred relationship | Existential restriction modifier | 1 | |
| Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Procedure context | Indicated | true | Inferred relationship | Existential restriction modifier | 1 | |
| Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Subject relationship context | Subject of record | true | Inferred relationship | Existential restriction modifier | 1 | |
| Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Associated procedure | Lipid-lowering therapy | true | Inferred relationship | Existential restriction modifier | 1 | |
| Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Is a | Lipid lowering therapy indicated | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Inclisiran indicated | Is a | True | Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Inferred relationship | Existential restriction modifier | |
| Evolocumab indicated | Is a | True | Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Inferred relationship | Existential restriction modifier | |
| Alirocumab indicated | Is a | True | Proprotein convertase subtilisin/kexin type 9 inhibitor indicated | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR